Clinical Trial Update: Comparison of Pharmacokinetics and Pharmacodynamics of Subcutaneous Versus Intravenous Administration of Bortezomib in Patients With Multiple Myeloma [Phase 1]

View source ↗

Summary

A Phase 1 trial comparing pharmacokinetics and pharmacodynamics of subcutaneous versus intravenous administration of bortezomib in patients with multiple myelom…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Bortezomib (bortezomib)

Snippet

Sponsor: Nantes University Hospital | Conditions: Multiple Myeloma | Phase 1 | Status: COMPLETED